The Original Investigation titled “Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer: An Ancillary Study of the NRG/RTOG 9601 Randomized Clinical Trial,”1 published online February 11, 2021, was corrected to change the article to open access under the CC-BY-NC-ND license. This article was corrected online.
Reference
- 1.Feng FY, Huang H-C, Spratt DE, et al. Validation of a 22-gene genomic classifier in patients with recurrent prostate cancer: an ancillary study of the NRG/RTOG 9601 randomized clinical trial. JAMA Oncol. Published online February 11, 2021. doi: 10.1001/jamaoncol.2020.7671 [DOI] [PMC free article] [PubMed] [Google Scholar]